Panagiotis Tsioufis
Overview
Explore the profile of Panagiotis Tsioufis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
93
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dimitriadis K, Soulaidopoulos S, Pyrpyris N, Sagris M, Aznaouridis K, Beneki E, et al.
J Am Heart Assoc
. 2025 Mar;
:e034932.
PMID: 40055145
Background: Patients with severe mitral regurgitation and cardiogenic shock demonstrate a poor prognosis. Mitral transcatheter edge-to-edge repair could alter patient management. Methods And Results: We systematically reviewed PubMed/Medline, Scopus, and...
2.
Karanikola A, Tzortzi M, Kordalis A, Doundoulakis I, Antoniou C, Laina A, et al.
J Clin Med
. 2025 Feb;
14(3).
PMID: 39941478
Atrial fibrillation (AF) is a supraventricular arrhythmia and the most common heart rhythm disorder in the adult population worldwide with an estimated prevalence of 2% to 4% of the population....
3.
Dimitriadis K, Iliakis P, Vakka A, Pyrpyris N, Pitsillidi A, Tsioufis P, et al.
Cardiol Rev
. 2025 Jan;
PMID: 39750025
Although metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed nonalcoholic fatty liver disease, has become the most common chronic liver disorder, its complex pathophysiology has not been fully elucidated up...
4.
Dimitriadis K, Iliakis P, Pyrpyris N, Tatakis F, Fragkoulis C, Mantziaris V, et al.
J Clin Med
. 2024 Nov;
13(22).
PMID: 39597800
Renal denervation (RDN), a transcatheter renal sympathetic nerve ablation procedure, is a relatively novel established procedure for the treatment of hypertension, with it being recognized as a third option for...
5.
Dimitriadis K, Pitsiori D, Alexiou P, Pyrpyris N, Sakalidis A, Beneki E, et al.
J Cardiovasc Pharmacol
. 2024 Oct;
85(1):12-20.
PMID: 39436317
Heart failure (HF) has become even more prevalent in recent years, because of improved diagnostics and an increase in the risk factors predisposing to its pathology. Sodium-glucose cotransporter 2 inhibitors...
6.
Dimitriadis K, Vakka A, Pyrpyris N, Apostolos A, Beneki E, Stathopoulou E, et al.
Am J Cardiovasc Drugs
. 2024 Oct;
25(1):57-69.
PMID: 39392560
Introduction: Contrast-induced acute kidney injury (CI-AKI) is a common complication of iodinated contrast administration during coronary procedures, especially in patients with diabetes mellitus (DM). Besides periprocedural hydration and statins, there...
7.
Dimitriadis K, Theofilis P, Koutsopoulos G, Pyrpyris N, Beneki E, Tatakis F, et al.
Heart Fail Rev
. 2024 Oct;
30(1):75-88.
PMID: 39358622
Heart failure with preserved ejection fraction (HFpEF) represents an entity with complex pathophysiologic pathways, among which coronary microvascular dysfunction (CMD) is believed to be an important orchestrator. Research in the...
8.
Dimitriadis K, Pyrpyris N, Sakalidis A, Dri E, Iliakis P, Tsioufis P, et al.
Cardiovasc Revasc Med
. 2024 Sep;
71:1-10.
PMID: 39341735
Lately, a large number of stable ischemic patients, with no obstructed coronary arteries are being diagnosed. Despite this condition, which is being described as angina with no obstructive coronary arteries...
9.
Iliakis P, Dimitriadis K, Pyrpyris N, Beneki E, Theofilis P, Tsioufis P, et al.
J Clin Med
. 2024 Sep;
13(17).
PMID: 39274249
Mitral regurgitation (MR) is one of the most common valvular pathologies worldwide, contributing to the morbidity and mortality of several cardiovascular pathologies, including heart failure (HF). Novel transcatheter treatment for...
10.
Dimitriadis K, Pyrpyris N, Iliakis P, Kanatas P, Theofilis P, Sakalidis A, et al.
J Cardiol
. 2024 Aug;
85(2):79-87.
PMID: 39134301
Percutaneous coronary interventions (PCI) are the mainstay of treating obstructive coronary artery disease. However, procedural planning and individualization of the procedure is necessary for different patient phenotypes to optimize outcomes....